<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37555900</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1613-7671</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>Suppl 4</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Wiener klinische Wochenschrift</Title><ISOAbbreviation>Wien Klin Wochenschr</ISOAbbreviation></Journal><ArticleTitle>[S1 guidelines for the management of postviral conditions using the example of post-COVID-19].</ArticleTitle><Pagination><StartPage>525</StartPage><EndPage>598</EndPage><MedlinePgn>525-598</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00508-023-02242-z</ELocationID><Abstract><AbstractText>These S1 guidelines are an updated and expanded version of the S1 guidelines on long COVID differential diagnostic and management strategies. They summarize the state of knowledge on postviral conditions like long/post COVID at the time of writing. Due to the dynamic nature of knowledge development, they are intended to be "living guidelines". The focus is on practical applicability at the level of primary care, which is understood to be the appropriate place for initial access and for primary care and treatment. The guidelines provide recommendations on the course of treatment, differential diagnostics of the most common symptoms that can result from infections like with SARS-CoV-2, treatment options, patient management and care, reintegration and rehabilitation. The guidelines have been developed through an interdisciplinary and interprofessional process and provide recommendations on interfaces and possibilities for collaboration.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rabady</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3603-5841</Identifier><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Str.&#xa0;30, 3500, Krems, &#xd6;sterreich. susanne.rabady@kl.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8760-4250</Identifier><AffiliationInfo><Affiliation>Leiterin der Abteilung Primary Care Medicine, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aigner</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4568-9836</Identifier><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Psychiatrie und psychotherapeutische Medizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Str.&#xa0;30, 3500, Krems, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altenberger</LastName><ForeName>Johann</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pensionsversicherungsanstalt, Rehabilitationszentrum Gro&#xdf;gmain, Salzburger Str.&#xa0;520, 5084, Gro&#xdf;gmain, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brose</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4902-4463</Identifier><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Str.&#xa0;30, 3500, Krems, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-6522-0678</Identifier><AffiliationInfo><Affiliation>Ergotherapie und Handlungswissenschaft, fhg&#xa0;- Zentrum f&#xfc;r Gesundheitsberufe Tirol GmbH/fh, Innrain&#xa0;98, 6020, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denk-Linnert</LastName><ForeName>Doris-Maria</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Allgemeine Hals&#x2011;, Nasen- und Ohrenkrankheiten, Klin. Abteilung Phoniatrie-Logop&#xe4;die, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruber</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Allgemeine Gesundheitsstudien, Kompetenzzentrum f&#xfc;r Allgemein- und Familienmedizin, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Dr. Karl-Dorrek-Str.&#xa0;30, 3500, Krems, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;tzinger</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Abteilung f&#xfc;r Kinderheilkunde, Klinik Ottakring, Montleartstr.&#xa0;37, 1160, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helbok</LastName><ForeName>Raimund</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Johannes Kepler Universit&#xe4;t Linz, Standort Neuromed Campus &amp; Med Campus Kepler Universit&#xe4;tsklinikum GmbH, 4020, Linz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;fner</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5453-8792</Identifier><AffiliationInfo><Affiliation>Dep. f&#xfc;r Psychiatrie, Psychotherapie, Psychosomatik und Medizinische Psychologie, Universit&#xe4;tsklinik f&#xfc;r Psychiatrie II, Medizinische Universit&#xe4;t Innsbruck, Anichstr.&#xa0;35, 6020, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koczulla</LastName><ForeName>Rembert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fachbereich Medizin, Klinik f&#xfc;r Pneumologie Marburg, Baldingerstr., 35035, Marburg, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4958-9541</Identifier><AffiliationInfo><Affiliation>Innere Medizin II, Medizinische Universit&#xe4;t Innsbruck, Anichstr.&#xa0;35, 6020, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamprecht</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3365-3449</Identifier><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Innere Medizin mit Schwerpunkt Pneumologie, Kepler Universit&#xe4;tsklinikum, 4020, Linz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leis</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4386-8497</Identifier><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie der PMU, MME Universit&#xe4;tsklinikum Salzburg Christian-Doppler-Klinik, Ignaz-Harrer-Str.&#xa0;79, 5020, Salzburg, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;ffler</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Innere Medizin II, Medizinische Universit&#xe4;t Innsbruck, Anichstr.&#xa0;35, 6020, Innsbruck, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Christian A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0001-6172-5417</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Allgemeine Hals&#x2011;, Nasen- und Ohrenkrankheiten, Klin. Abteilung f&#xfc;r Allgemeine HNO, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rittmannsberger</LastName><ForeName>Hans</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6567-4677</Identifier><AffiliationInfo><Affiliation>Pyhrn-Eisenwurzen Klinikum Steyr, Sierninger Str.&#xa0;170, 4400, Steyr, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rommer</LastName><ForeName>Paulus S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Universit&#xe4;tsklinik f&#xfc;r Neurologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sator</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Dermatologische Abteilung, Klinik Hietzing, Wolkersbergenstr.&#xa0;1, 1130, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strenger</LastName><ForeName>Volker</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-6947-5894</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Allgemeinp&#xe4;diatrie, Universit&#xe4;tsklinik f&#xfc;r Kinder- und Jugendheilkunde, Medizinische Universit&#xe4;t Graz, 8036, Graz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struhal</LastName><ForeName>Walter</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-7360-7784</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Neurologie, Universit&#xe4;tsklinikum Tulln, Karl Landsteiner Privatuniversit&#xe4;t f&#xfc;r Gesundheitswissenschaften, Alter Ziegelweg&#xa0;10, 3430, Tulln an der Donau, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Untersmayr</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1963-499X</Identifier><AffiliationInfo><Affiliation>Institut f&#xfc;r Pathophysiologie und Allergieforschung Zentrum f&#xfc;r Pathophysiologie, Infektiologie und Immunologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vonbank</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2930-7252</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Pulmologie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wancata</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4951-6780</Identifier><AffiliationInfo><Affiliation>Klinische Abteilung f&#xfc;r Sozialpsychiatrie, Medizinische Universit&#xe4;t Wien, W&#xe4;hringer G&#xfc;rtel 18-20, 1090, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0617-0417</Identifier><AffiliationInfo><Affiliation>Kardiologische Abteilung Klinikum Wels-Grieskirchen, Grieskirchnerstr.&#xa0;42, 4600, Wels, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3660-5637</Identifier><AffiliationInfo><Affiliation>&#xc4;rztin f&#xfc;r Allgemeinmedizin, 8046, Graz, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwick</LastName><ForeName>Ralf-Harun</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Rehabilitation Research, Kurbadstr.&#xa0;14, 1100, Wien, &#xd6;sterreich.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Leitlinie S1 f&#xfc;r das Management postviraler Zust&#xe4;nde am Beispiel Post-COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Wien Klin Wochenschr</MedlineTA><NlmUniqueID>21620870R</NlmUniqueID><ISSNLinking>0043-5325</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008511" MajorTopicYN="Y">Medicine</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Die vorliegende Leitlinie S1 ist die Aktualisierung und Weiterentwicklung der Leitlinie S1 Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der Kenntnis zu postviralen Zust&#xe4;nden anhand des Beispiels Long/Post COVID zum Zeitpunkt des Redaktionsschlusses zusammen. Aufgrund der starken Dynamik der Wissensentwicklung versteht sie sich als &#x201e;living guideline&#x201c;. Der Schwerpunkt liegt auf der praktischen Anwendbarkeit auf der Ebene der haus&#xe4;rztlichen Prim&#xe4;rversorgung, die als geeignete Stelle f&#xfc;r den Erstzutritt und f&#xfc;r die prim&#xe4;re Betreuung und Behandlung verstanden wird. Die Leitlinie gibt Empfehlungen zum Versorgungsgang, zu Differenzialdiagnostik der h&#xe4;ufigsten Symptome, die in der Folge einer Infektion wie mit SARS-CoV&#x2011;2 auftreten k&#xf6;nnen, zu therapeutischen Optionen, zu Patient:innenf&#xfc;hrung und -betreuung sowie zur Wiedereingliederung in den Alltag und zur Rehabilitation. Entsprechend des Krankheitsbildes ist die Leitlinie in einem interdisziplin&#xe4;ren und interprofessionellen Prozess entstanden und gibt Empfehlungen zu Schnittstellen und Kooperationsm&#xf6;glichkeiten.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infectious diseases</Keyword><Keyword MajorTopicYN="N">Long term consequences</Keyword><Keyword MajorTopicYN="N">Long term sequelae</Keyword><Keyword MajorTopicYN="N">Persisting symptoms</Keyword><Keyword MajorTopicYN="N">Post-infectious condition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>12</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>11</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37555900</ArticleId><ArticleId IdType="pmc">PMC10504206</ArticleId><ArticleId IdType="doi">10.1007/s00508-023-02242-z</ArticleId><ArticleId IdType="pii">10.1007/s00508-023-02242-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Costa U. Leitfaden f&#xfc;r das Management von Folgen viraler Erkrankung mit SARS-CoV-2 aus Sicht der Ergotherapie. Erg&#xe4;nzung zur Leitlinie S1 f&#xfc;r das Management postviraler Zust&#xe4;nde am Beispiel Post-COVID-19. Wien Klin. Wochenschr.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10504210</ArticleId><ArticleId IdType="pubmed">37522912</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a&#xa0;cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR Themed Review: Living with Covid19&#x2014;Second review. 2021. 10.3310/themedreview_45225. Zugegriffen: 5. Februar 2023.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation> Interview with Elisa Perego, Ph.D., on Long COVID and Social Media&#x2014;Long COVID Initiative (aboutlongcovid.org). https://aboutlongcovid.org/interview-with-elisa-perego-phd-on-long-covid-and-social-media/. Zugegriffen: 5. Jan. 2023.</Citation></Reference><Reference><Citation> Kate auf Twitter: &#x201e;@felicitycallard Oh that&#x2019;s funny &#x2026; it absolutely came from Amy. She named the group that because of her favorite trucker hat she wore when she got tested. https://twitter.com/katemeredithp/status/1277316840453267456. Zugegriffen: 5. Jan. 2023.</Citation></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med. 2022;28(5):879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, et al. The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization. Sci Rep. 2022;12(1):14505. doi: 10.1038/s41598-022-18673-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18673-z</ArticleId><ArticleId IdType="pmc">PMC9403954</ArticleId><ArticleId IdType="pubmed">36008436</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55. 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health O. Clinical management of COVID-19: living guideline. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation> Langfassung S3-Leitlinie M&#xfc;digkeit. https://register.awmf.org/assets/guidelines/053-002l_S3_Muedigkeit_2023-01_01.pdf. Zugegriffen: 17. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation> AWMF S1-Leitlinie Long/ Post-COVID. https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2022-08.pdf. Zugegriffen: 3. Febr. 2023.</Citation></Reference><Reference><Citation>Excellence NNIfHaC. Excellence NNIfHaC. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. https://www.nice.org.uk/guidance/ng206 (Erstellt: 29. Okt. 2021). Zugegriffen: 2. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Marx, V. Scientists set out to connect the dots on long COVID. Nat Methods 18, 449&#x2013;453 (2021). 10.1038/s41592-021-01145-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8081406</ArticleId><ArticleId IdType="pubmed">33911230</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12). 10.1093/ofid/ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). NICE guideline (NG188): COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. Zugegriffen: 25. Febr. 2023.</Citation></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . A clinical case definition of post COVID-19 condition by a&#xa0;Delphi consensus. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Long COVID or post-COVID conditions. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Zugegriffen: 10. Febr. 2023.</Citation></Reference><Reference><Citation>T&#xf6;pfner N, Alberer M, Ankermann T, et al. Recommendation for standardized medical care for children and adolescents with long COVID. Monatsschr Kinderheilkd. 2022;170(6):539&#x2013;547. doi: 10.1007/s00112-021-01408-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00112-021-01408-1</ArticleId><ArticleId IdType="pmc">PMC9131710</ArticleId><ArticleId IdType="pubmed">35637934</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. 2020.</Citation></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Group ftGAC-P-ACS Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation> Prevalence of post COVID-19 condition symptoms: a&#xa0;systematic review and meta-analysis of cohort study data, stratified by recruitment setting. https://www.ecdc.europa.eu/sites/default/files/documents/Prevalence-post-COVID-19-condition-symptoms.pdf. Zugegriffen: 4. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco JVA, Garegnani LI, Oltra GV, et al. Long-term health symptoms and sequelae following SARS-coV&#x2011;2 infection: an evidence map. Int J Environ Res Public Health. 2022;19(16):9915. 10.3390/ijerph19169915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="pubmed">36011562</ArticleId></ArticleIdList></Reference><Reference><Citation>RKI. Scoping review und evidence maps zu long Covid. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Long-COVID/Scoping-Review.html. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899&#x2013;100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Lim EY, Mactavous L, et al. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. 2022;81:104129. doi: 10.1016/j.ebiom.2022.104129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104129</ArticleId><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, Hoffmann K, Brose M, et al. Symptoms and risk factors for hospitalization of COVID-19 presented in primary care : An exploratory retrospective study. Wien Klin Wochenschr. 2022;134(9-10):335&#x2013;343. doi: 10.1007/s00508-021-01992-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01992-y</ArticleId><ArticleId IdType="pmc">PMC8852901</ArticleId><ArticleId IdType="pubmed">35149931</ArticleId></ArticleIdList></Reference><Reference><Citation> FACING THE IMPACT OF POST-COVID-19 CONDITION (LONG COVID) ON HEALTH SYSTEMS Opinion of the Expert Panel on effective ways of investing in health (EXPH). https://health.ec.europa.eu/system/files/2022-12/031_longcovid_en.pdf. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, et al. Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6(3):e235763. doi: 10.1001/jamanetworkopen.2023.5763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, et al. Association of self-reported COVID-19 infection and SARS-coV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh K, Larsen TG, Hansen CB, et al. Self-reported long COVID and its association with the presence of SARS-coV-2 antibodies in a&#xa0;Danish cohort up to 12 months after infection. Microbiol Spectr. 2022;10(6):e0253722. doi: 10.1128/spectrum.02537-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02537-22</ArticleId><ArticleId IdType="pmc">PMC9769646</ArticleId><ArticleId IdType="pubmed">36350150</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt CT, Wiese L, Christiansen KM, Agergaard J. Antibodies to nucleocapsid are not diagnostic for long COVID. Microbiol Spectr. 2023;11(2):e0490022. doi: 10.1128/spectrum.04900-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.04900-22</ArticleId><ArticleId IdType="pmc">PMC10100955</ArticleId><ArticleId IdType="pubmed">36809148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, et al. One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals. J Intern Med. 2022;292(1):103&#x2013;115. doi: 10.1111/joim.13482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13482</ArticleId><ArticleId IdType="pmc">PMC9115262</ArticleId><ArticleId IdType="pubmed">35555926</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a&#xa0;prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437&#xa0;patients. Lancet Psychiatry. 2022;9(10):815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziyad Al-Aly BB, Xie Y, et al. Outcomes of SARS-CoV&#x2011;2 Reinfection. (Erstellt: 17. Juni 2022. 10.21203/rs.3.rs-1749502/v1, PREPRINT (Version 1) available at Research Square. Zugegriffen: 10. Jan. 2023.</Citation></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, et al. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;580. 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6&#xa0;months after COVID-19 in non-hospitalised subjects: a&#xa0;population-based cohort study. Thorax. 2021;76(4):405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3&#xa0;months after a&#xa0;SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2013;895.e820. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S, et al. The conundrum of &#x2018;long-COVID-19&#x2019;: a narrative review. Int J Gen Med. 2021;14:2491&#x2013;2506. doi: 10.2147/IJGM.S316708.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pmc">PMC8214209</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie&#xdf; AM, Bloch W, Friedmann-Bette B, Grim C, Halle M, Hirschm&#xfc;ller A, Kopp C, Meyer T, Niebauer J, Reinsberger C,R&#xf6;cker K, Scharhag J, Scherr J, Schneider C, Steinacker JM, Urhausen A, Wolfarth B, Mayer F. Position stand: return to sport in the current Coronavirus pandemic (SARS-CoV-2 / COVID-19). Dtsch Z Sportmed. 2020;71:E1&#x2013;E4. 10.5960/dzsm.2020.437.</Citation></Reference><Reference><Citation>Elliott N, Martin R, Heron N, Elliott J, Grimstead D, Biswas A. Infographic. Graduated return to play guidance following COVID-19 infection. Br J Sports Med. 2020;54(19):1174&#x2013;1175. doi: 10.1136/bjsports-2020-102637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102637</ArticleId><ArticleId IdType="pmc">PMC7371566</ArticleId><ArticleId IdType="pubmed">32571796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The Relationship between Physical Activity and Long COVID: A Cross-Sectional Study. Int J Environ Res Public Health. 2022;19:5093. 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschke D, Houston D. The impact of Long COVID on the UK workforce. Appl Econ Lett. 2022; 1&#x2013;5. 10.1080/13504851.2022.2098239.</Citation></Reference><Reference><Citation>Shutters ST. Modelling long-term COVID-19 impacts on the U.S. workforce of 2029. PLoS ONE. 2021;16(12):e0260797. doi: 10.1371/journal.pone.0260797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260797</ArticleId><ArticleId IdType="pmc">PMC8635400</ArticleId><ArticleId IdType="pubmed">34852022</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Oraibi A, Woolf K, Nellums LB, Tarrant C, Naqvi H, Pareek M. Caring for the carers: understanding long covid in our diverse healthcare workforce. BMJ. 2022;377:o1152. doi: 10.1136/bmj.o1152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1152</ArticleId><ArticleId IdType="pubmed">35523438</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a&#xa0;cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ. Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician. Curr Atheroscler Rep. 2022;24(7):563&#x2013;570. doi: 10.1007/s11883-022-01032-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01032-8</ArticleId><ArticleId IdType="pmc">PMC9065238</ArticleId><ArticleId IdType="pubmed">35507278</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Shibata K, Hellyer PJ, et al. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun. 2022;4(1):fcab295. doi: 10.1093/braincomms/fcab295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab295</ArticleId><ArticleId IdType="pmc">PMC8807287</ArticleId><ArticleId IdType="pubmed">35128398</ArticleId></ArticleIdList></Reference><Reference><Citation>Govender M, Hopkins FR, Goransson R, et al. T cell perturbations persist for at least 6&#xa0;months following hospitalization for COVID-19. Front Immunol. 2022;13:931039. doi: 10.3389/fimmu.2022.931039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.931039</ArticleId><ArticleId IdType="pmc">PMC9393525</ArticleId><ArticleId IdType="pubmed">36003367</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8&#xa0;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y, Luo L, Chen Y, et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduct Target Ther. 2021;6(1):345. doi: 10.1038/s41392-021-00749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00749-3</ArticleId><ArticleId IdType="pmc">PMC8456405</ArticleId><ArticleId IdType="pubmed">34552055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: Hair loss and sexual dysfunction are among wider symptoms, study finds. BMJ. 2022;378:o1887. doi: 10.1136/bmj.o1887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1887</ArticleId><ArticleId IdType="pubmed">35896202</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. 2021;325(19):2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M, Kim S, Lindsell C, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, march&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020;69. 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rensen AIV, Spiliopoulos L, Bager P, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13(1):4213. doi: 10.1038/s41467-022-31897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31897-x</ArticleId><ArticleId IdType="pmc">PMC9302226</ArticleId><ArticleId IdType="pubmed">35864108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133(3). 10.1172/JCI163669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10(6):763. doi: 10.3390/pathogens10060763.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, Graninger M, Lettenmaier L, et al. Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Allergy. 2023;78(1):297&#x2013;299. doi: 10.1111/all.15471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammi V, Ollila HM. Tackling Long COVID using international host genetics research collaboration. Sleep Med. 2022;100:S64&#x2013;S65. doi: 10.1016/j.sleep.2022.05.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2022.05.184</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, et al. Distinguishing features of Long COVID identified through immune profiling. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, Wig N. The &#x201c;post-COVID&#x201d; syndrome: How deep is the damage? J Med Virol. 2021;93(2):673&#x2013;674. doi: 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26465</ArticleId><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopanska M, Batoryna M, Bartman P, Szczygielski J, Banas-Zabczyk A. Disorders of the Cholinergic system in COVID-19 era&#x2014;A review of the latest research. Int J Mol Sci. 2022;23(2). 10.3390/ijms23020672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775685</ArticleId><ArticleId IdType="pubmed">35054856</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman JP, McKlveen JM, Ghosal S, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603&#x2013;621. doi: 10.1002/cphy.c150015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c150015</ArticleId><ArticleId IdType="pmc">PMC4867107</ArticleId><ArticleId IdType="pubmed">27065163</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi: 10.1016/j.autrev.2020.102597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemian N, Kao D, Pakpour S. Fecal microbiota transplantation during and post-COVID-19 pandemic. Int J Mol Sci. 2021;22(6):3004. doi: 10.3390/ijms22063004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063004</ArticleId><ArticleId IdType="pmc">PMC7998826</ArticleId><ArticleId IdType="pubmed">33809421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhan H, Zhang F, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159(4):1302&#x2013;1310.e1305. doi: 10.1053/j.gastro.2020.06.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.06.048</ArticleId><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955.e8. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570):eabd3876. doi: 10.1126/scitranslmed.abd3876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon K, Casali P. Nature and functions of autoantibodies. Nature clinical practice. Rheumatology. 2008;4(9):491&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703183</ArticleId><ArticleId IdType="pubmed">18756274</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):15. doi: 10.1038/s41413-018-0016-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-018-0016-9</ArticleId><ArticleId IdType="pmc">PMC5920070</ArticleId><ArticleId IdType="pubmed">29736302</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E, et al. Signatures of Mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. 2022;12(11). 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z. Endotheliitis bei COVID-19. Pathologe. 2020;41(2):99&#x2013;102. doi: 10.1007/s00292-020-00875-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00292-020-00875-9</ArticleId><ArticleId IdType="pmc">PMC7731145</ArticleId><ArticleId IdType="pubmed">33306138</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2022;1&#x2013;15. 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MA, Knauer MJ, Nicholson M, et al. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a&#xa0;key pathophysiological mechanism. Mol Med. 2022;28(1):122. doi: 10.1186/s10020-022-00548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00548-8</ArticleId><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Naidoo CA, Usher TJ, et al. Increased levels of inflammatory molecules in blood of Long COVID patients point to thrombotic endotheliitis. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A, Vasaikar SV, Lemos MP, et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. 2021.</Citation></Reference><Reference><Citation>von Meijenfeldt FA, Havervall S, Adelmeijer J, et al. Sustained prothrombotic changes in COVID-19&#xa0;patients 4&#xa0;months after hospital discharge. Blood Adv. 2021;5(3):756&#x2013;759. doi: 10.1182/bloodadvances.2020003968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher AK, Burnham KL, Jones EM, et al. Transcriptional reprogramming from innate immune functions to a&#xa0;pro-thrombotic signature by monocytes in COVID-19. Nat Commun. 2022;13(1):7947. doi: 10.1038/s41467-022-35638-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35638-y</ArticleId><ArticleId IdType="pmc">PMC9791976</ArticleId><ArticleId IdType="pubmed">36572683</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight R, Walker V, Ip S, et al. Association of COVID-19 with major arterial and venous thrombotic diseases: a population&#x2014;wide cohort study of 48 million adults in england and Wales. Circulation. 2022;146:892&#x2013;906. doi: 10.1161/CIRCULATIONAHA.122.060785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060785</ArticleId><ArticleId IdType="pmc">PMC9484653</ArticleId><ArticleId IdType="pubmed">36121907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas A, Schurman SH, Franceschi C, Ferrucci L. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging? Immun Ageing. 2020;17(1):23. doi: 10.1186/s12979-020-00196-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00196-8</ArticleId><ArticleId IdType="pmc">PMC7443812</ArticleId><ArticleId IdType="pubmed">32849908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A, Barbi V, Gottardi Zamperla M, et al. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int J Mol Sci. 2021;22(11). 10.3390/ijms22116151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Putrino D. Why we need a&#xa0;deeper understanding of the pathophysiology of long COVID. Lancet Infect Dis. 2023;23(4):393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann DH, Tsukahara T, Weinreb C, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):eabc5801. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu A, Fischbein N, Wintermark M, Zaharchuk G, Yun PT, Zeineh M. COVID-19-induced anosmia associated with olfactory bulb atrophy. Neuroradiology. 2021;63(1):147&#x2013;148. doi: 10.1007/s00234-020-02554-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-020-02554-1</ArticleId><ArticleId IdType="pmc">PMC7490479</ArticleId><ArticleId IdType="pubmed">32930820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischer M, Szepanowski F, Tovar M, et al. Post-COVID-19 syndrome is rarely associated with damage of the nervous system: findings from a&#xa0;prospective observational cohort study in 171 patients. Neurol Ther. 2022;11(4):1637&#x2013;1657. doi: 10.1007/s40120-022-00395-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-022-00395-z</ArticleId><ArticleId IdType="pmc">PMC9417089</ArticleId><ArticleId IdType="pubmed">36028604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kase Y, Sonn I, Goto M, Murakami R, Sato T, Okano H. The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures. Exp Neurol. 2023;363:114379. doi: 10.1016/j.expneurol.2023.114379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2023.114379</ArticleId><ArticleId IdType="pmc">PMC10008041</ArticleId><ArticleId IdType="pubmed">36914084</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E, Klotz S, Beyerle M, et al. Multifactorial white matter damage in the acute phase and pre-existing conditions May drive cognitive dysfunction after SARS-coV-2 infection: neuropathology-based evidence. Viruses. 2023;15(4):908. doi: 10.3390/v15040908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040908</ArticleId><ArticleId IdType="pmc">PMC10144140</ArticleId><ArticleId IdType="pubmed">37112888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, et al. Risk for newly diagnosed diabetes after COVID-19: a&#xa0;systematic review and meta-analysis. BMC Med. 2022;20(1):444. doi: 10.1186/s12916-022-02656-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02656-y</ArticleId><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4). 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. Measles virus-induced suppression of immune responses. Immunol Rev. 2010;236:176&#x2013;189. doi: 10.1111/j.1600-065X.2010.00925.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00925.x</ArticleId><ArticleId IdType="pmc">PMC2908915</ArticleId><ArticleId IdType="pubmed">20636817</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina MJ, Kula T, Leng Y, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019;366(6465):599&#x2013;606. doi: 10.1126/science.aay6485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay6485</ArticleId><ArticleId IdType="pmc">PMC8590458</ArticleId><ArticleId IdType="pubmed">31672891</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeaumont D, Boujibar F, Ferrand-Devouge E, et al. Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization&#x2014;A pilot study. Phys Ther. 2021; Volume 101, Issue 6, June 2021, pzab099. 10.1093/ptj/pzab099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989156</ArticleId><ArticleId IdType="pubmed">33735374</ArticleId></ArticleIdList></Reference><Reference><Citation>Regmi B, Friedrich J, J&#xf6;rn B, et al. Diaphragm muscle weakness might explain exertional dyspnea fifteen months after hospitalization for COVID-19. Am J Respir Crit Care Med. 2023. 10.1164/rccm.202206-1243OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112448</ArticleId><ArticleId IdType="pubmed">36596223</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18(5):799&#x2013;806. doi: 10.1513/AnnalsATS.202008-1002OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Culebras M, Loor K, Sansano I, et al. Histological findings in transbronchial cryobiopsies obtained from patients after COVID-19. Chest. 2022;161(3):647&#x2013;650. doi: 10.1016/j.chest.2021.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8464080</ArticleId><ArticleId IdType="pubmed">34582842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Long-term lung abnormalities associated with COVID-19 pneumonia. Radiology. 2022;221806. 10.1148/radiol.221806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Luger AK, Sonnweber T, Gruber L, et al. Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study. Radiology. 2022;304(2):462&#x2013;470. doi: 10.1148/radiol.211670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.211670</ArticleId><ArticleId IdType="pmc">PMC8988857</ArticleId><ArticleId IdType="pubmed">35348379</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et al. Health outcomes in people 2&#xa0;years after surviving hospitalisation with COVID-19: a&#xa0;longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med. 2021;9(1):107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells AU, Devaraj A, Desai SR. Interstitial lung disease after COVID-19 infection: a catalog of uncertainties. Radiology. 2021;299(1):E216&#x2013;E218. doi: 10.1148/radiol.2021204482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204482</ArticleId><ArticleId IdType="pmc">PMC7841875</ArticleId><ArticleId IdType="pubmed">33502279</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo F, Bulau JE, Semper H, Grohe C. Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome. Infection. 2022;1&#x2013;4. 10.1007/s15010-022-01899-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9379900</ArticleId><ArticleId IdType="pubmed">35972679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, Villacreses R, Nagpal P, et al. Quantitative chest CT assessment of small airways disease in post-acute SARS-coV-2 infection. Radiology. 2022;304(1):185&#x2013;192. doi: 10.1148/radiol.212170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, Sun K, Tahir P, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(10):e2236057. doi: 10.1001/jamanetworkopen.2022.36057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Fresard I, Genecand L, Altarelli M, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in &#x2018;long COVID&#x2019; patients with persistent dyspnoea. BMJ Open Respir Res. 2022;9(1). 10.1136/bmjresp-2021-001126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968537</ArticleId><ArticleId IdType="pubmed">35354589</ArticleId></ArticleIdList></Reference><Reference><Citation>von Gruenewaldt A, Nylander E, Hedman K. Classification and occurrence of an abnormal breathing pattern during cardiopulmonary exercise testing in subjects with persistent symptoms following COVID-19 disease. Physiol Rep. 2022;10(4):e15197. doi: 10.14814/phy2.15197.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15197</ArticleId><ArticleId IdType="pmc">PMC8855681</ArticleId><ArticleId IdType="pubmed">35179831</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidbreder A, Sonnweber T, Stefani A, et al. Video-polysomnographic findings after acute COVID-19: REM sleep without atonia as sign of CNS pathology? Sleep Med. 2021;80:92&#x2013;95. doi: 10.1016/j.sleep.2021.01.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2021.01.051</ArticleId><ArticleId IdType="pmc">PMC7985859</ArticleId><ArticleId IdType="pubmed">33588262</ArticleId></ArticleIdList></Reference><Reference><Citation>Group TWCftCS Four-month clinical status of a&#xa0;cohort of patients after hospitalization for COVID-19. JAMA. 2021;325(15):1525&#x2013;1534. doi: 10.1001/jama.2021.3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a&#xa0;prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EL, Go&#xdf;ling A, Adam G, et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme. Eur Heart J. 2022;43(11):1124&#x2013;1137. doi: 10.1093/eurheartj/ehab914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab914</ArticleId><ArticleId IdType="pmc">PMC8755397</ArticleId><ArticleId IdType="pubmed">34999762</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla A, Ankermann T, Behrends U, et al. S1-Leitlinie Post-COVID/Long-COVID. 2021.</Citation></Reference><Reference><Citation>Writing C, Gluckman TJ, Bhave NM, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-coV-2 infection, and return to play: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2022;79(17):1717&#x2013;1756. doi: 10.1016/j.jacc.2022.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi &#xc1;, Ybarra-Falc&#xf3;n C, Garc&#xed;a-G&#xf3;mez M, et al. Exercise ventilatory inefficiency in post-COVID-19 syndrome: insights from a prospective evaluation. J Clin Med. 2021;10(12). 10.3390/jcm10122591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8230788</ArticleId><ArticleId IdType="pubmed">34208271</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Croft LB, Stefanini GG, et al. Characterization of Myocardial Injury in Patients With COVID&#x2013;19. J Am Coll Cardiol. 2020;76(18):2043&#x2013;2055. doi: 10.1016/j.jacc.2020.08.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.069</ArticleId><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Coats AJS, Tsutsui H, et al. Universal definition and classification of heart failure: a&#xa0;report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021;23(3):352&#x2013;380. doi: 10.1002/ejhf.2115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2115</ArticleId><ArticleId IdType="pubmed">33605000</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a&#xa0;port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri VP, Riefolo M, Lazzarotto T, et al. COVID-19 and the brain: the neuropathological Italian experience on 33 adult autopsies. Biomolecules. 2022;12(5). 10.3390/biom12050629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9138268</ArticleId><ArticleId IdType="pubmed">35625558</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, et al. Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol. 2022;91(1):150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarius S, Pache F, K&#xf6;rtvelyessy P, et al. Cerebrospinal fluid findings in COVID-19: a&#xa0;multicenter study of 150 lumbar punctures in 127&#xa0;patients. J Neuroinflammation. 2022;19(1):19. doi: 10.1186/s12974-021-02339-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02339-0</ArticleId><ArticleId IdType="pmc">PMC8771621</ArticleId><ArticleId IdType="pubmed">35057809</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Sabadia S, Lalchan R, et al. A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York city. Neurology. 2021;96(4):e575&#x2013;e586. doi: 10.1212/WNL.0000000000010979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010979</ArticleId><ArticleId IdType="pmc">PMC7905791</ArticleId><ArticleId IdType="pubmed">33020166</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators C-MD Global prevalence and burden of depressive and anxiety disorders in 204&#xa0;countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700&#x2013;1712. doi: 10.1016/S0140-6736(21)02143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02143-7</ArticleId><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, et al. Characterizing long COVID: deep phenotype of a&#xa0;complex condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlit P, et al. Neurologische Manifestationen bei COVID-19, S1-Leitlinie. In: Deutsche Gesellschaft f&#xfc;r Neurologieet al., editors. Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie. 2021.</Citation></Reference><Reference><Citation>Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr&#xe9; syndrome. Brain. 2020;144(2):682&#x2013;693. doi: 10.1093/brain/awaa433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa433</ArticleId><ArticleId IdType="pmc">PMC7799186</ArticleId><ArticleId IdType="pubmed">33313649</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain&#x2013;Barr&#xe9; syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73&#xa0;cases. J Neurol. 2021;268(4):1133&#x2013;1170. doi: 10.1007/s00415-020-10124-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10124-x</ArticleId><ArticleId IdType="pmc">PMC7445716</ArticleId><ArticleId IdType="pubmed">32840686</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID and smell loss: answers begin to emerge. Nature. 2022;606(7915):631&#x2013;632. doi: 10.1038/d41586-022-01589-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01589-z</ArticleId><ArticleId IdType="pubmed">35681006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig B, Olbert E, Trimmel K, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: an overview of current evidence. Nervenarzt. 2023; 1&#x2013;9. 10.1007/s00115-022-01431-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9875188</ArticleId><ArticleId IdType="pubmed">36695893</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al. Neurological outcome and quality of life 3&#xa0;months after COVID-19: a prospective observational cohort study. Eur J Neurol. 2021;28(10):3348&#x2013;3359. doi: 10.1111/ene.14803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021;144(4):1263&#x2013;1276. doi: 10.1093/brain/awab009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab009</ArticleId><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazhenets G, Schr&#xf6;ter N, Bormann T, et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med. 2021. 10.2967/jnumed.121.262128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882885</ArticleId><ArticleId IdType="pubmed">33789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiatkittikul P, Promteangtrong C, Kunawudhi A, et al. Abnormality pattern of F-18 FDG PET whole body with functional MRI brain in post-acute COVID-19. Nucl Med Mol Imaging. 2022;56(1):29&#x2013;41. doi: 10.1007/s13139-021-00730-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13139-021-00730-6</ArticleId><ArticleId IdType="pmc">PMC8760088</ArticleId><ArticleId IdType="pubmed">35069924</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripongsatian D, Kunawudhi A, Promteangtrong C, et al. Alterations in 18F-FDG PET/MRI and 15O-water PET brain findings in patients with neurological symptoms after COVID-19 vaccination: a pilot study. Clin Nucl Med. 2022;47(3):e230&#x2013;e239. doi: 10.1097/RLU.0000000000004041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000004041</ArticleId><ArticleId IdType="pmc">PMC8820745</ArticleId><ArticleId IdType="pubmed">35025789</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Basso MR, Naini SM, et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6&#xa0;months post-infection part 1: cognitive functioning. Clin Neuropsychol. 2022;36(4):806&#x2013;828. doi: 10.1080/13854046.2022.2030412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030412</ArticleId><ArticleId IdType="pubmed">35130818</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside DM, Naini SM, Basso MR, et al. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6&#xa0;months post-infection part 2: psychological functioning. Clin Neuropsychol. 2022;36(4):829&#x2013;847. doi: 10.1080/13854046.2022.2030411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2022.2030411</ArticleId><ArticleId IdType="pubmed">35098861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Ashton NJ, Andersson LM, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020;95(12):e1754&#x2013;e1759. doi: 10.1212/WNL.0000000000010111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010111</ArticleId><ArticleId IdType="pubmed">32546655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N, Simr&#xe9;n J, Ed&#xe9;n A, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512. doi: 10.1016/j.ebiom.2021.103512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ak&#x131;nc&#x131; B, O&#x11f;ul &#xd6;, Hano&#x11f;lu L, et al. Evaluation of cognitive functions in adult individuals with COVID-19. Neurol Sci. 2023;44(3):793&#x2013;802. doi: 10.1007/s10072-022-06562-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06562-2</ArticleId><ArticleId IdType="pmc">PMC9793347</ArticleId><ArticleId IdType="pubmed">36574178</ArticleId></ArticleIdList></Reference><Reference><Citation>Therapists RCoO. Post-COVID Syndrome (Long Covid). https://www.rcot.co.uk/post-covid-syndrome-long-covid. Zugegriffen: 1. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Watters K, Marks TS, Edwards DF, Skidmore ER, Giles GM. A framework for addressing clients&#x2019; functional cognitive deficits after COVID-19. Am J Occup Ther. 2021;75(Supplement_1):7511347010p1&#x2013;7511347010p7. doi: 10.5014/ajot.2021.049308.</Citation><ArticleIdList><ArticleId IdType="doi">10.5014/ajot.2021.049308</ArticleId><ArticleId IdType="pubmed">34405800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho PA. Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management. Headache. 2022;62(6):650&#x2013;656. doi: 10.1111/head.14319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14319</ArticleId><ArticleId IdType="pmc">PMC9348060</ArticleId><ArticleId IdType="pubmed">35545780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Cuadrado ML, G&#xf3;mez-Mayordomo V, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L. Headache as a&#xa0;COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant. Expert Rev Neurother. 2023;23(2):179&#x2013;186. doi: 10.1080/14737175.2023.2185138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2023.2185138</ArticleId><ArticleId IdType="pubmed">36857191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, et al. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820&#x2013;3825. doi: 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hashel JY, Abokalawa F, Alenzi M, Alroughani R, Ahmed SF. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a&#xa0;cross-sectional study. J Headache Pain. 2021;22(1):97. doi: 10.1186/s10194-021-01314-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01314-7</ArticleId><ArticleId IdType="pmc">PMC8380111</ArticleId><ArticleId IdType="pubmed">34418950</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Rodr&#xed;guez-Jim&#xe9;nez J, Fuensalida-Novo S, et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. PAIN. 2021;162(12):2832&#x2013;2840. 10.1097/j.pain.0000000000002306.</Citation><ArticleIdList><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022;9(3). 10.1212/nxi.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65(4):440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, Wu S, Mera RM, Costa AF, Recalde BY, Issa NP. Cognitive decline among individuals with history of mild symptomatic SARS-CoV&#x2011;2 infection: A longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021. 10.1111/ene.14775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Heu&#xdf; D, et al. Diagnostik und Differenzialdiagnose bei Myalgien, S1-Leitlinie. In: Deutsche Gesellschaft f&#xfc;r Neurologieet al., editors. Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie. 2020.</Citation></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive and mental health impacts of COVID-19 following hospitalisation&#x2014;a&#xa0;multi-centre prospective cohort study. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xfc;&#xdf; H. Langzeitfolgen von COVID-19. https://www.neurodiem.at/news/langzeitfolgen-von-covid-19-5cTFQ5DN2eONaO9FrgZ191. Zugegriffen: 10. Jan. 2023.</Citation></Reference><Reference><Citation>Saniasiaya J, Islam MA, Abdullah B. Prevalence of olfactory dysfunction in Coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope. 2021;131(4):865&#x2013;878. doi: 10.1002/lary.29286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29286</ArticleId><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucidi, D, Molinari, G, Silvestri, M, et al. Patient-reported olfactory recovery after SARS-CoV-2 infection: A 6-month follow-up study. Int Forum Allergy Rhinol. 2021;11:1249&#x2013;1252. 10.1002/alr.22775.</Citation><ArticleIdList><ArticleId IdType="pubmed">33539667</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health. Trends Mol Med. 2022;28(9):781&#x2013;794. doi: 10.1016/j.molmed.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B, Liu DT, Besser G, et al. Long-lasting olfactory dysfunction in COVID-19&#xa0;patients. Eur Arch Otorhinolaryngol. 2022;279(7):3485&#x2013;3492. doi: 10.1007/s00405-021-07153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Sabha M, Damm M, et al. Parosmia is associated with relevant olfactory recovery after olfactory training. Laryngoscope. 2021;131(3):618&#x2013;623. doi: 10.1002/lary.29277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29277</ArticleId><ArticleId IdType="pubmed">33210732</ArticleId></ArticleIdList></Reference><Reference><Citation>S2k-Leitlinie 017/050: Riech- und Schmeckst&#xf6;rungen. https://www.awmf.org/uploads/tx_szleitlinien/017-050l_S2k_Riech-und-Schmeckst%C3%B6rungen_2021-04.pdf. Zugegriffen: 28. Juni. 2021.</Citation></Reference><Reference><Citation>Cantarella G, Ald&#xe8; M, Consonni D, et al. Prevalence of Dysphonia in non hospitalized patients with COVID-19 in Lombardy, the Italian epicenter of the pandemic. J Voice. 2021;37(4):605&#x2013;609. 10.1016/j.jvoice.2021.03.009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955941</ArticleId><ArticleId IdType="pubmed">33766419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadd K, Moyse K, Enderby P. Impact of COVID-19 on the speech and language therapy profession and their patients. Front Neurol. 2021;12(96). 10.3389/fneur.2021.629190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930219</ArticleId><ArticleId IdType="pubmed">33679590</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziewas R, Hufelschulte LM, Lepper J, et al. Dysphagia in patients with severe Coronavirus disease 2019-potential neurologic etiologies. Crit Care Explor. 2021;3(1):e0332. doi: 10.1097/CCE.0000000000000332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000332</ArticleId><ArticleId IdType="pmc">PMC7837983</ArticleId><ArticleId IdType="pubmed">33521647</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviv JE, Chandrasekhar S, Thomashow B. Covid-19 era post viral vagal neuropathy presenting as persistent shortness of breath with normal pulmonary imaging. Int J Pul Res Sci. 2020;4(4):555641. doi: 10.19080/IJOPRS.2020.04.555641.</Citation><ArticleIdList><ArticleId IdType="doi">10.19080/IJOPRS.2020.04.555641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiekens C, Boldrini P, Andreoli A, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. &#x201c;Instant paper from the field&#x201d; on rehabilitation answers to the COVID-19 emergency. Eur J Phys Rehabil Med. 2020;56(3):323&#x2013;326. doi: 10.23736/S1973-9087.20.06305-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06305-4</ArticleId><ArticleId IdType="pubmed">32293817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Cabaraux P, et al. Features of mild-to-moderate COVID-19 patients with Dysphonia. J Voice. 2020;36(2)249&#x2013;255. 10.1016/j.jvoice.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269945</ArticleId><ArticleId IdType="pubmed">32600873</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodsky MB, Gilbert RJ. The long-term effects of COVID-19 on Dysphagia evaluation and treatment. Arch Phys Med Rehabil. 2020;101(9):1662&#x2013;1664. doi: 10.1016/j.apmr.2020.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7286637</ArticleId><ArticleId IdType="pubmed">32534801</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson JM, Govender R, Roe J, et al. COVID-19 and ENT SLT services, workforce and research in the UK: a discussion paper. Int J Lang Commun Disord. 2020;55(5):806&#x2013;817. doi: 10.1111/1460-6984.12565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1460-6984.12565</ArticleId><ArticleId IdType="pmc">PMC7436215</ArticleId><ArticleId IdType="pubmed">32770652</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan R, Mohapatra B. Shedding light on dysphagia associated with COVID-19: the what and why. OTO Open. 2020;4(2):2473974X20934770. doi: 10.1177/2473974X20934770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2473974X20934770</ArticleId><ArticleId IdType="pmc">PMC7281885</ArticleId><ArticleId IdType="pubmed">32551409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, et al. Long COVID guidelines need to reflect lived experience. Lancet. 2021;397(10273):455&#x2013;457. doi: 10.1016/S0140-6736(20)32705-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SK, Iezzi CM, Gilpin L. Swallowing and voice outcomes in patients hospitalized with COVID-19: an observational cohort study. Arch Phys Med Rehabil. 2021;102(6):1084&#x2013;1090. doi: 10.1016/j.apmr.2021.01.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.01.063</ArticleId><ArticleId IdType="pmc">PMC7846878</ArticleId><ArticleId IdType="pubmed">33529610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilic O, Kalcioglu MT, Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208&#x2013;211. doi: 10.1016/j.ijid.2020.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.023</ArticleId><ArticleId IdType="pmc">PMC7289736</ArticleId><ArticleId IdType="pubmed">32535294</ArticleId></ArticleIdList></Reference><Reference><Citation>Welge-Luessen A, Hummel T, Stojan T, Wolfensberger M. What is the correlation between ratings and measures of olfactory function in patients with olfactory loss? Am J Rhinol. 2005;19(6):567&#x2013;571. doi: 10.1177/194589240501900606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/194589240501900606</ArticleId><ArticleId IdType="pubmed">16402642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller CA, Grassinger E, Naka A, Temmel AFP, Hummel T, Kobal G. A self-administered odor identification test procedure using the &#x201c;Sniffin&#x2019; sticks&#x201d;. Chem Senses. 2006;31(6):595&#x2013;598. doi: 10.1093/chemse/bjj064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjj064</ArticleId><ArticleId IdType="pubmed">16754696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Whitcroft KL, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2016;56(1):1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">28623665</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleszkiewicz A, Schriever VA, Croy I, H&#xe4;hner A, Hummel T. Updated Sniffin&#x2019; Sticks normative data based on an extended sample of 9139 subjects. Eur Arch Otorhinolaryngol. 2019;276(3):719&#x2013;728. doi: 10.1007/s00405-018-5248-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-018-5248-1</ArticleId><ArticleId IdType="pmc">PMC6411676</ArticleId><ArticleId IdType="pubmed">30554358</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Besser G, Renner B, Seyferth S, Hummel T, Mueller CA. Retronasal olfactory function in patients with smell loss but subjectively normal flavor perception. Laryngoscope. 2020;130(7):1629&#x2013;1633. doi: 10.1002/lary.28258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28258</ArticleId><ArticleId IdType="pmc">PMC7318622</ArticleId><ArticleId IdType="pubmed">31471971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a&#xa0;systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese G, Moltrasio C, Berti E, Marzano AV. Skin manifestations associated with COVID-19: current knowledge and future perspectives. Dermatology. 2021;237(1):1&#x2013;12. doi: 10.1159/000512932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512932</ArticleId><ArticleId IdType="pmc">PMC7801998</ArticleId><ArticleId IdType="pubmed">33232965</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA. Fact sheet for healthcare providers administering vaccine (vaccination providers). https://www.fda.gov/media/144413/download. Zugegriffen: 26. Juni 2021.</Citation></Reference><Reference><Citation>Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2021;2:119&#x2013;133. doi: 10.1016/j.jdin.2020.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdin.2020.12.003</ArticleId><ArticleId IdType="pmc">PMC7754879</ArticleId><ArticleId IdType="pubmed">33479703</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade SB, Siqueira S, de Assis Soares WR, et al. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4). 10.3390/v13040700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, et al. Long COVID in the skin: a&#xa0;registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314. doi: 10.1016/S1473-3099(20)30986-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis. 2021;102:53&#x2013;55. doi: 10.1016/j.ijid.2020.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.021</ArticleId><ArticleId IdType="pmc">PMC7566763</ArticleId><ArticleId IdType="pubmed">33075530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D, et al. Phenotyping of acute and persistent Coronavirus disease 2019 features in the outpatient setting: exploratory analysis of an international cross-sectional Online survey. Clin Infect Dis. 2022;75(1):e418&#x2013;e431. doi: 10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Ausserhofer D, et al. Who is at risk of poor mental health following Coronavirus disease-19 outpatient management? Front Med. 2022;9:792881. doi: 10.3389/fmed.2022.792881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.792881</ArticleId><ArticleId IdType="pmc">PMC8964263</ArticleId><ArticleId IdType="pubmed">35360744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;1091. doi: 10.1001/jamapsychiatry.2022.2640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Korompoki E, Gavriatopoulou M, Hicklen RS, et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83(1):1&#x2013;16. doi: 10.1016/j.jinf.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8118709</ArticleId><ArticleId IdType="pubmed">33992686</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;-Mart&#xed;nez V, Luperdi SC, et al. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors. J Intern Med. 2021. 10.1111/joim.13262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013333</ArticleId><ArticleId IdType="pubmed">33533521</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;147. doi: 10.1016/j.bbi.2021.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Piccinelli SC, et al. COVID-19 severity impacts on long-term neurological manifestation after hospitalisation. 2021.</Citation></Reference><Reference><Citation>Jebrini T, Reinhard MA, Ortmann M, et al. Psychiatric complications of COVID-19: The unknown disease (Long Covid) MMW Fortschr Med. 2021;163(9):48&#x2013;50. doi: 10.1007/s15006-021-9888-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15006-021-9888-5</ArticleId><ArticleId IdType="pmc">PMC8103131</ArticleId><ArticleId IdType="pubmed">33961259</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Pallar&#xe9;s JG, Buend&#xed;a-Romero &#xc1;, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021;18(10). 10.3390/ijerph18105329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Brito-Zer&#xf3;n P, Conangla Ferr&#xed;n L, et al. Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8). 10.3390/ijerph18084350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetti F, Mazza M, Cavalli G, Ciceri F, Dagna L, Rovere-Querini P. Can cytokine blocking prevent depression in COVID-19 survivors? J Neuroimmune Pharmacol. 2021;16(1):1&#x2013;3. doi: 10.1007/s11481-020-09966-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-020-09966-z</ArticleId><ArticleId IdType="pmc">PMC7587545</ArticleId><ArticleId IdType="pubmed">33107012</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lorenzo R, Cinel E, Cilla M, et al. Physical and psychological sequelae at three months after acute illness in COVID-19 survivors. Panminerva Med. 2021. 10.23736/s0031-0808.21.04399-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34060280</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Andresen V, Van den Bergh O, et al. Persistent SOMAtic symptoms ACROSS diseases&#x2014;from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211) BMJ Open. 2022;12(1):e057596. doi: 10.1136/bmjopen-2021-057596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057596</ArticleId><ArticleId IdType="pmc">PMC8785206</ArticleId><ArticleId IdType="pubmed">35063961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Luger AK, et al. COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial. ERJ Open Res. 2023;9(2). 10.1183/23120541.00317-2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10030059</ArticleId><ArticleId IdType="pubmed">36960350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: A systematic review. Front Med. 2023;10:1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. 2023;108(1):12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc Diabetol. 2022;21(1):148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022;479(16):1653&#x2013;1708. doi: 10.1042/BCJ20220154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R, Cuffaro L, Capozza A, et al. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. J Neurol. 2023;270(4):1823&#x2013;1834. doi: 10.1007/s00415-022-11543-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11543-8</ArticleId><ArticleId IdType="pmc">PMC9873215</ArticleId><ArticleId IdType="pubmed">36692636</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesj&#xf6; F, Sayyab S, Karlsson L, et al. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin Epigenetics. 2022;14(1):172. doi: 10.1186/s13148-022-01398-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId><ArticleId IdType="pmc">PMC9748378</ArticleId><ArticleId IdType="pubmed">36517875</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Sahanic S, et al. Persistent somatic symptoms are key to individual illness perception at one year after COVID-19 in a&#xa0;cross-sectional analysis of a&#xa0;prospective cohort study. J Psychosom Res. 2023;169:111234. doi: 10.1016/j.jpsychores.2023.111234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111234</ArticleId><ArticleId IdType="pmc">PMC10022460</ArticleId><ArticleId IdType="pubmed">36965396</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Grubwieser P, Sahanic S, et al. The impact of iron Dyshomeostasis and anaemia on long-term pulmonary recovery and persisting symptom burden after COVID-19: a prospective observational cohort study. Metabolites. 2022;12(6). 10.3390/metabo12060546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9228477</ArticleId><ArticleId IdType="pubmed">35736479</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Sahanic S, et al. Persistent somatic symptoms are key to individual illness perception at one year after COVID-19. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10022460</ArticleId><ArticleId IdType="pubmed">36965396</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders C, Sperling S, Bendstrup E. A new paradigm is needed to explain long COVID. Lancet Respir Med. 2023;11(2):e12&#x2013;e13. doi: 10.1016/S2213-2600(22)00501-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00501-X</ArticleId><ArticleId IdType="pubmed">36620963</ArticleId></ArticleIdList></Reference><Reference><Citation> S3 Leitlinie &#x201e;Funktionelle K&#xf6;rperbeschwerden&#x201c;. https://register.awmf.org/assets/guidelines/051-001l_S3_Funktionelle_Koerperbeschwerden_2018-11.pdf. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Health PRUWCCiM. WHO (F&#xfc;nf) &#x2013; Fragebogen zum Wohlbefinden (Version 1998). https://www.psykiatri-regionh.dk/who-5/Documents/WHO5_German.pdf. Zugegriffen: 20. Juli 2021.</Citation></Reference><Reference><Citation> GAD&#x2011;2. https://de.wikipedia.org/wiki/GAD-2#/media/Datei:GAD-2.tif. Zugegriffen: 20. Juli 2021.</Citation></Reference><Reference><Citation>I S, C S. Deutsche Version des &#x201e;Primary Care Posttraumatic Stress Disorder screening questionnaire&#x201c;. Universit&#xe4;t Hamburg. 2021.</Citation></Reference><Reference><Citation>Baumgartner JS, Jahn R, Friedrich F, Alexandrowicz RW, Wancata J. Die Kriteriumsvalidit&#xe4;t der 15-Item Geriatrischen Depressionsskala in der &#xf6;sterreichischen Bev&#xf6;lkerung. Psychiatr Prax. 2019;46(04):206&#x2013;212. doi: 10.1055/a-0822-7578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0822-7578</ArticleId><ArticleId IdType="pubmed">30641611</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrowicz R, Weiss M, Marquart B, Wancata J. Zur Validit&#xe4;t eines zweistufigen Screenings am Beispiel des Depressionsscreening. Psychiatr Prax. 2008;35(06):294&#x2013;301. doi: 10.1055/s-2008-1067335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2008-1067335</ArticleId><ArticleId IdType="pubmed">18504689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapra A, Bhandari P. StatPearls. Treasure Island: StatPearls Publishing; 2021. Chronic fatigue syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">32491608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med. 2005;55(1):20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a&#xa0;narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzinger F, Santiago-Garc&#xed;a B, Noguera-Juli&#xe1;n A, et al. COVID-19 in children and adolescents in Europe: a&#xa0;multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653&#x2013;661. doi: 10.1016/S2352-4642(20)30177-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30177-2</ArticleId><ArticleId IdType="pmc">PMC7316447</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6). 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Roland D, De Rose C, et al. Schools closures during the COVID-19 pandemic: a catastrophic global situation. Pediatr Infect Dis J. 2021;40(4):e146&#x2013;e150. doi: 10.1097/INF.0000000000003052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003052</ArticleId><ArticleId IdType="pubmed">33464019</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. 2021;110(3):914&#x2013;921. doi: 10.1111/apa.15673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV&#x2011;2. Lancet Child Adolesc Health. 2021. 10.1016/s2352-4642(21)00198-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607&#x2013;1608. doi: 10.1016/S0140-6736(20)31094-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31094-1</ArticleId><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a&#xa0;pediatric inflammatory multisystem syndrome temporally associated with SARS-coV-2. JAMA. 2020;324(3):259&#x2013;269. doi: 10.1001/jama.2020.10369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10369</ArticleId><ArticleId IdType="pmc">PMC7281356</ArticleId><ArticleId IdType="pubmed">32511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968&#x2013;981.e7. doi: 10.1016/j.cell.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Zugegriffen: 24. Jan. 2023.</Citation></Reference><Reference><Citation>Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC. Acute covid-19 and multisystem inflammatory syndrome in children. BMJ. 2021;372:n385. doi: 10.1136/bmj.n385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n385</ArticleId><ArticleId IdType="pubmed">33648933</ArticleId></ArticleIdList></Reference><Reference><Citation>Feleszko W, Okarska-Napiera&#x142;a M, Buddingh EP, et al. Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper. Pediatr Allergy Immunol. 2023;34(1):e13900. doi: 10.1111/pai.13900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13900</ArticleId><ArticleId IdType="pubmed">36705045</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Allin B, Jones CE, et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a&#xa0;national Delphi process. Lancet Child Adolesc Health. 2021;5(2):133&#x2013;141. doi: 10.1016/S2352-4642(20)30304-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30304-7</ArticleId><ArticleId IdType="pmc">PMC7500943</ArticleId><ArticleId IdType="pubmed">32956615</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Andre MC, Grazioli S, et al. Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-coV-2 (PIMS-TS; Multisystem inflammatory syndrome in children, MIS-C) in Switzerland. Front Pediatr. 2021;9:667507. doi: 10.3389/fped.2021.667507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.667507</ArticleId><ArticleId IdType="pmc">PMC8187755</ArticleId><ArticleId IdType="pubmed">34123970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowska M, Lukasik ZM, Agache I, et al. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives&#x2014;A report of the European Academy of Allergy and Clinical Immunology (EAACI) Allergy. 2020;75(10):2445&#x2013;2476. doi: 10.1111/all.14462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14462</ArticleId><ArticleId IdType="pmc">PMC7361752</ArticleId><ArticleId IdType="pubmed">32584441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wen W, Fan X, et al. COVID-19 immune features revealed by a&#xa0;large-scale single-cell transcriptome atlas. Cell. 2021;184(7):1895&#x2013;1913.e9. doi: 10.1016/j.cell.2021.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.053</ArticleId><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz L, Rohrhofer J, Zehetmayer S, Stingl M, Untersmayr E. Evaluation of immune dysregulation in an Austrian patient cohort suffering from myalgic encephalomyelitis/chronic fatigue syndrome. Biomolecules. 2021;11(9). 10.3390/biom11091359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8465819</ArticleId><ArticleId IdType="pubmed">34572574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulcri C, Dentone C, Mikulska M, et al. The longest persistence of viable SARS-coV-2 with recurrence of Viremia and relapsing symptomatic COVID-19 in an immunocompromised patient&#x2014;A case study. Open Forum Infect Dis. 2021;8(11):ofab217. doi: 10.1093/ofid/ofab217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab217</ArticleId><ArticleId IdType="pmc">PMC8135455</ArticleId><ArticleId IdType="pubmed">34796242</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758&#x2013;763. doi: 10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A, Koch R, Jukic A, et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163(2):495&#x2013;506.e8. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515). 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S, et al. Autoantibodies to vasoregulative G&#x2011;protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med. 2021;10(16). 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Filgueiras IS, Kedor C, et al. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front Immunol. 2022;13:981532. doi: 10.3389/fimmu.2022.981532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Li H, Murphy TA, et al. Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018;7(8). 10.1161/JAHA.117.008351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015435</ArticleId><ArticleId IdType="pubmed">29618472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahearn-Ford S, Lunjani N, McSharry B, et al. Long-term disruption of cytokine signalling networks is evident in patients who required hospitalization for SARS-CoV-2 infection. Allergy. 2021;76(9):2910&#x2013;2913. doi: 10.1111/all.14953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14953</ArticleId><ArticleId IdType="pmc">PMC8222932</ArticleId><ArticleId IdType="pubmed">34028045</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020;75(11):2764&#x2013;2774. doi: 10.1111/all.14407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14407</ArticleId><ArticleId IdType="pmc">PMC7300800</ArticleId><ArticleId IdType="pubmed">32500526</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022;77(4):1288&#x2013;1291. doi: 10.1111/all.15188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P, Akin C, Bonadonna P, et al. Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome. J Allergy Clin Immunol Pract. 2019;7(4):1125&#x2013;1133.e1. doi: 10.1016/j.jaip.2019.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.01.006</ArticleId><ArticleId IdType="pmc">PMC6643056</ArticleId><ArticleId IdType="pubmed">30737190</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P, Akin C, Hartmann K, et al. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hemasphere. 2021;5(11):e646. doi: 10.1097/HS9.0000000000000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HS9.0000000000000646</ArticleId><ArticleId IdType="pmc">PMC8659997</ArticleId><ArticleId IdType="pubmed">34901755</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler CR, Austen KF, Akin C, et al. AAAAI mast cell disorders committee work group report: mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol. 2019;144(4):883&#x2013;896. doi: 10.1016/j.jaci.2019.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.08.023</ArticleId><ArticleId IdType="pubmed">31476322</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Scheibenbogen C. Wenn COVID nicht aufh&#xf6;rt: Post-COVID-Verl&#xe4;ufe mit Fatigue und Belastungsintoleranz. Dtsch Med Wochenschr. 2022;147(20):1320&#x2013;1330. doi: 10.1055/a-1849-8953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1849-8953</ArticleId><ArticleId IdType="pubmed">36195090</ArticleId></ArticleIdList></Reference><Reference><Citation> Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023. Zugegriffen: 30. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Long-term symptoms in Canadian adults who tested positive for COVID-19 or suspected an infection, January 2020 to August 2022. https://www150.statcan.gc.ca/n1/daily-quotidien/221017/dq221017b-eng.htm. Zugegriffen: 16. Februar 2023.</Citation></Reference><Reference><Citation>Holl FCW, Resch T, Partheym&#xfc;ller J. Long Covid in &#xd6;sterreich: H&#xe4;ufigkeit und Symptome. 2022. https://viecer.univie.ac.at/corona-blog/corona-blog-beitraege/blog-154-long-covid-in-oesterreich-haeufigkeit-und-symptome/. Zugegriffen: 16. Februar 2023.</Citation></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomed Health Behav. 2020;8(2):61&#x2013;69.</Citation></Reference><Reference><Citation>Hejb&#xf8;l EK, Harbo T, Agergaard J, et al. Myopathy as a&#xa0;cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29(9):2832&#x2013;2841. doi: 10.1111/ene.15435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15435</ArticleId><ArticleId IdType="pmc">PMC9348124</ArticleId><ArticleId IdType="pubmed">35661354</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CLMC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020;5:50&#x2013;58. doi: 10.1016/j.cnp.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2018;6:242. doi: 10.3389/fped.2018.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00242</ArticleId><ArticleId IdType="pmc">PMC6131594</ArticleId><ArticleId IdType="pubmed">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Uta B. Screening auf Post-Exertionelle-Malaise (PEM) Fragebogen. https://cfc.charite.de/fileadmin/user_upload/microsites/kompetenzzentren/cfc/Landing_Page/DSQ-PEM_TUM.pdf (Erstellt: 4. Sept. 2021). Zugegriffen: 20. Jan. 2023.</Citation></Reference><Reference><Citation> S2k-LL SARS-CoV&#x2011;2, COVID-19 und (Fr&#xfc;h&#x2011;) Rehabilitation, S2k-Leitlinie (&#x201e;Living guideline&#x201c;). https://register.awmf.org/assets/guidelines/080-008l_S2k_SARS-CoV-2_COVID-19_und_Frueh-_Rehabilitation_2022-11.pdf. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence SIGNaRCoGP. COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa U,Einzigartigkeit macht es aus: Ergotherapie f&#xfc;r Menschen &#x201e;postCovid&#x201c;. Annual Meeting Ergotherapie Austria. Innsbruck (Austria)11. M&#xe4;rz 2022.</Citation></Reference><Reference><Citation>Sperl LCU. Long&#x2011;/Post COVID Anhaltende Symptome bei Personen nach einer COVID-19 Infektion. Ergotherapie. 2022;2:36&#x2013;37.</Citation></Reference><Reference><Citation>Theoharides TC. Potential association of mast cells with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(3):217&#x2013;218. doi: 10.1016/j.anai.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7644430</ArticleId><ArticleId IdType="pubmed">33161155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV&#x2011;2 between matched long- and short-COVID groups. Br J Psychiatry. 2023 Feb;222(2):74-81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany&#x2014;a&#xa0;first analysis of a&#xa0;prospective observational study. 2021.</Citation></Reference><Reference><Citation>Hersche R, Weise A. Occupational therapy-based energy management education in people with post-COVID-19 condition-related fatigue: results from a&#xa0;focus group discussion. Occup Ther Int. 2022;2022:4590154. doi: 10.1155/2022/4590154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4590154</ArticleId><ArticleId IdType="pmc">PMC9023185</ArticleId><ArticleId IdType="pubmed">35521629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmaud A, Anota A, Moncharmont C, et al. Cancer-related fatigue management: evaluation of a&#xa0;patient education program with a&#xa0;large-scale randomised controlled trial, the PEPs fatigue study. Br J Cancer. 2017;116(7):849&#x2013;858. doi: 10.1038/bjc.2017.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjc.2017.31</ArticleId><ArticleId IdType="pmc">PMC5379143</ArticleId><ArticleId IdType="pubmed">28196066</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesellschaft DF. Ursachen. https://deutsche-fatigue-gesellschaft.de/fatigue/ursachen/. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Reis Carneiro D, Rocha I, Habek M, et al. Clinical presentation and management strategies of cardiovascular autonomic dysfunction following a COVID-19 infection&#x2014;A systematic review. Eur J Neurol. 2023. 10.1111/ene.15714.</Citation><ArticleIdList><ArticleId IdType="pubmed">36694382</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;368. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Guzman JC, Harvey P, et al. Canadian Cardiovascular Society position statement on postural Orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol. 2020;36(3):357&#x2013;372. doi: 10.1016/j.cjca.2019.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2019.12.024</ArticleId><ArticleId IdType="pubmed">32145864</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;194(10):E378&#x2013;E385. doi: 10.1503/cmaj.211373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211373</ArticleId><ArticleId IdType="pmc">PMC8920526</ArticleId><ArticleId IdType="pubmed">35288409</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, Russell JW, L&#xf6;scher WN, Grisold W. Atlas of neuromuscular diseases A practical guideline. Vienna: Springer-Verlag Wien 2014.</Citation></Reference><Reference><Citation>Fanciulli A, Campese N, Wenning GK. The Schellong test: detecting orthostatic blood pressure and heart rate changes in German-speaking countries. Clin Auton Res. 2019;29(4):363&#x2013;366. doi: 10.1007/s10286-019-00619-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00619-7</ArticleId><ArticleId IdType="pubmed">31273549</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883&#x2013;1948. doi: 10.1093/eurheartj/ehy037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy037</ArticleId><ArticleId IdType="pubmed">29562304</ArticleId></ArticleIdList></Reference><Reference><Citation>Norcliffe-Kaufmann L, Palma JA, Kaufmann H. A validated test for neurogenic orthostatic hypotension at the bedside. Ann Neurol. 2018;84(6):959&#x2013;960. doi: 10.1002/ana.25362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25362</ArticleId><ArticleId IdType="pmc">PMC6396675</ArticleId><ArticleId IdType="pubmed">30341962</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs RD, Brignole M, Falup-Pecurariu C, et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness : Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN) Clin Auton Res. 2021;31(3):369&#x2013;384. doi: 10.1007/s10286-020-00738-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00738-6</ArticleId><ArticleId IdType="pmc">PMC8184725</ArticleId><ArticleId IdType="pubmed">33740206</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid&#x2014;an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation> Guide P&#x2011;ACTP, Affairs USDoV. Whole-Health-System-Approach-to-Long-COVID_080122_FINAL. https://www.publichealth.va.gov/n-coronavirus/docs/Whole-Health-System-Approach-to-Long-COVID_080122_FINAL.pdf. Zugegriffen: 10. Febr. 2023.</Citation></Reference><Reference><Citation>Informationen zu Long COVID f&#xfc;r Bev&#xf6;lkerung, Betroffene und Fachpersonal. https://www.sozialministerium.at/Corona/allgemeine-informationen/long-covid.html#versorgung-von-long-covid-betroffenen. Zugegriffen: 14. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Allgemeinmedizin und Familienmedizin. Fachdefinition DEGAM. https://www.degam.de/fachdefinition. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>WONCA. The European Definition of GP / FM. https://www.woncaeurope.org/page/definition-of-general-practice-family-medicine. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Berger Z, Altiery DE, Jesus V, Assoumou SA, Greenhalgh T. Long COVID and health inequities: the role of primary care. Milbank Q. 2021;99(2):519&#x2013;541. doi: 10.1111/1468-0009.12505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12505</ArticleId><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation> Eine Leitlinie &#x201e;Long/Post-COVID-Syndrom&#x201c; f&#xfc;r Betroffene, Angeh&#xf6;rige, nahestehende und pflegende Personen, die sich auf eine &#xe4;rztliche Leitlinie st&#xfc;tzt (&#x201e;S1-Leitlinie Long&#x2011;/Post-COVID&#x201c; der AWMF; Registernummer 020-027). https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=&amp;cad=rja&amp;uact=8&amp;ved=2ahUKEwitkOnn_oj-AhVFNOwKHUiOBCAQFnoECAkQAQ&amp;url=https%3A%2F%2Fregister.awmf.org%2Fassets%2Fguidelines%2F020-027p_S1_Post_COVID_Long_COVID_2023-02.pdf&amp;usg=AOvVaw37Poiht4r9oqe9fDHY-a_A. Zugegriffen: 2. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Rabady S, Altenberger J, Brose M, et al. Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Wien Klin Wochenschr. 2021;133(7):237&#x2013;278. doi: 10.1007/s00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance H, Maslach A, Stoneman E, et al. Addressing post-COVID symptoms: a guide for primary care physicians. J Am Board Fam Med. 2021;34(6):1229&#x2013;1242. doi: 10.3122/jabfm.2021.06.210254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2021.06.210254</ArticleId><ArticleId IdType="pubmed">34772779</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevention CCfDCa. Post-COVID conditions: information for healthcare providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation> Screening auf Post-Exertionelle-Malaise (PEM) &#x2013; Fragebogen. https://cfc.charite.de/fileadmin/user_upload/microsites/kompetenzzentren/cfc/Landing_Page/DSQ-PEM_TUM.pdf. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Roenneberg C, Sattel H, Schaefert R, Henningsen P, Hausteiner-Wiehle C. Functional somatic symptoms. Dtsch &#xc4;rztebl Int. 2019;116(33&#x2013;34):553&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794707</ArticleId><ArticleId IdType="pubmed">31554544</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Do TP, Remmers A, Schytz HW, et al. Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 2019;92(3):134&#x2013;144. doi: 10.1212/WNL.0000000000006697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006697</ArticleId><ArticleId IdType="pmc">PMC6340385</ArticleId><ArticleId IdType="pubmed">30587518</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG&#x2011;I, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021. 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger K, Gehrke-Beck S, Holzinger F, Heintze C. DEGAM Leitlinie Husten, Kurzversion. 2021.</Citation></Reference><Reference><Citation>DEGAM. DEGAM-Leitlinien. https://www.degam.de/degam-leitlinien-379. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>2023 Mini-Cog(c). Quick Screening for Early Dementia Detection. https://mini-cog.com/. Zugegriffen: 23.03.2023.</Citation></Reference><Reference><Citation>Abholz H, Jendyk R. DEGAM Leitlinie &#x201c;Akuter Schwindel&#x201d;, Kurzversion. 2016.</Citation></Reference><Reference><Citation>al. DRe. Synkopen, S1-Leitlinie, 2020, in: Deutsche Gesellschaft f&#xfc;r Neurologie (Hrsg.), Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie. www.dgn.org/leitlinien. Accessed 25. Jan. 2023.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Allgemeinmedizin und Familienmedizin . Insomnie bei Erwachsenen &#x2013; DEGAM-Anwenderversion zur S3 Leitlinie &#x201e;Nicht erholsamer Schlaf/Schlafst&#xf6;rungen&#x201c;. Berlin: DEGAM; 2017.</Citation></Reference><Reference><Citation>Deutsche Gesellschaft f&#xfc;r Schlafforschung und Schlafmedizin . S3-Leitlinie Nicht erholsamer Schlaf/Schlafst&#xf6;rungen &#x2013; Schlafbezogene Atmungsst&#xf6;rungen. 2016.</Citation></Reference><Reference><Citation>Fawzy NA, Abou Shaar B, Taha RM, Arabi TZ, Sabbah BN, Alkodaymi MS, Omrani OA, Makhzoum T, Almahfoudh NE, Al-Hammad QA, Hejazi W, Obeidat Y, Osman N, Al-Kattan KM, Berbari EF, Tleyjeh IM. A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on WHO International Clinical Trials Platform. Clin Microbiol Infect. 2023;29(5):570&#x2013;577. doi: 10.1016/j.cmi.2023.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.01.007</ArticleId><ArticleId IdType="pmc">PMC9837206</ArticleId><ArticleId IdType="pubmed">36642173</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health O . Clinical management of COVID-19: living guideline. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus. 2021;5:100025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Abonie US, Edwards AM, Hettinga FJ. Optimising activity pacing to promote a&#xa0;physically active lifestyle in medical settings: a narrative review informed by clinical and sports pacing research. J Sports Sci. 2020;38(5):590&#x2013;596. doi: 10.1080/02640414.2020.1721254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02640414.2020.1721254</ArticleId><ArticleId IdType="pubmed">31997716</ArticleId></ArticleIdList></Reference><Reference><Citation>World Physiotherapy briefing paper focuses on safe rehabilitation for people living with Long COVID. https://world.physio/news/world-physiotherapy-briefing-paper-focuses-safe-rehabilitation-people-living-long-covid. Zugegriffen: 26. Februar 2023.</Citation></Reference><Reference><Citation>Puchner B, Sahanic S, Kirchmair R, et al. Beneficial effects of multi-disciplinary rehabilitation in postacute COVID-19: an observational cohort study. Eur J Phys Rehabil Med. 2021;57(2):189&#x2013;198. doi: 10.23736/S1973-9087.21.06549-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.21.06549-7</ArticleId><ArticleId IdType="pubmed">33448756</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A, Davison J, Tarrant R, et al. A multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J Prim Care Community Health. 2021;12:21501327211010994. doi: 10.1177/21501327211010994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschlb&#xf6;ck S, Wenning G, Fanciulli A. Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. J Neural Transm. 2017;124(12):1567&#x2013;1605. doi: 10.1007/s00702-017-1791-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-017-1791-y</ArticleId><ArticleId IdType="pmc">PMC5686257</ArticleId><ArticleId IdType="pubmed">29058089</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH) Clin Auton Res. 2018;28(4):355&#x2013;362. doi: 10.1007/s10286-018-0529-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-018-0529-8</ArticleId><ArticleId IdType="pmc">PMC6097730</ArticleId><ArticleId IdType="pubmed">29766366</ArticleId></ArticleIdList></Reference><Reference><Citation>Struhal WHL, Fanciulli A, Wenning GK. Bedside approach to autonomic disorders. Cham: Springer; 2017.</Citation></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, et al. Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope. 2014;124(4):826&#x2013;831. doi: 10.1002/lary.24340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Altundag A, Cayonu M, Kayabasoglu G, et al. Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. 2015;125(8):1763&#x2013;1766. doi: 10.1002/lary.25245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.25245</ArticleId><ArticleId IdType="pubmed">26031472</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DT, Pellegrino R, Sabha M, et al. Factors associated with relevant olfactory recovery after olfactory training: a retrospective study including 601 participants. Rhinology. 2020. 10.4193/Rhin20.262.</Citation><ArticleIdList><ArticleId IdType="pubmed">32901616</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinc AS, Sengezer T, Cayonu M, Sahin MM. Smoking cessation improves olfactory functions. Laryngoscope. 2020;130(2):E35&#x2013;E38. doi: 10.1002/lary.27992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.27992</ArticleId><ArticleId IdType="pubmed">30953390</ArticleId></ArticleIdList></Reference><Reference><Citation>Pence TS, Reiter ER, DiNardo LJ, Costanzo RM. Risk factors for hazardous events in olfactory-impaired patients. JAMA Otolaryngol Head Neck Surg. 2014;140(10):951&#x2013;955. doi: 10.1001/jamaoto.2014.1675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2014.1675</ArticleId><ArticleId IdType="pubmed">25170573</ArticleId></ArticleIdList></Reference><Reference><Citation> Microbiology NR. Table 1 Summary of candidate treatments and supporting evidence. https://www.nature.com/articles/s41579-022-00846-2/tables/1. Zugegriffen: 19. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Salman D, Vishnubala D, Le Feuvre P, et al. Returning to physical activity after covid-19. BMJ. 2021;372:m4721. doi: 10.1136/bmj.m4721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4721</ArticleId><ArticleId IdType="pubmed">33419740</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Rayner C, Delaney B. Fresh evidence of the scale and scope of long covid. BMJ. 2021;373:n853. doi: 10.1136/bmj.n853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n853</ArticleId><ArticleId IdType="pubmed">33795224</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1). 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharhag J, Niebauer J, Schobersberger W. &#x201e;Return to Sports&#x201c; im (Hoch&#x2011;)Leistungssport nach COVID-19. Konsensus der sportmedizinischen Universit&#xe4;ts- und Landesinstitute Wien, Salzburg und Innsbruck. https://salk.at/DMS/Konsens%20RTP%20Covid%20Wien%20Salzburg%20Innsbruck_20111940.pdf. Zugegriffen: 2. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Hughes DC, Orchard JW, Partridge EM, La Gerche A, Broderick C. Return to exercise post-COVID-19 infection: a pragmatic approach in mid-2022. J Sci Med Sport. 2022;25(7):544&#x2013;547. doi: 10.1016/j.jsams.2022.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsams.2022.06.001</ArticleId><ArticleId IdType="pmc">PMC9170595</ArticleId><ArticleId IdType="pubmed">35725689</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrisch-Rahmel S. COVID-19 und return to play. https://sportaerztezeitung.com/rubriken/training/1050/covid-19-und-return-to-play/. Zugegriffen: 2. M&#xe4;rz 2023.</Citation></Reference><Reference><Citation>Steinacker JM, Schellenberg J, Bloch W, et al. Recommendations for return-to-sport after COVID-19: expert consensus. Dtsch Z Sportmed. 2022;73(4):127&#x2013;136.</Citation></Reference><Reference><Citation>Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC) Eur Heart J. 2019;40(1):19&#x2013;33. doi: 10.1093/eurheartj/ehy730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy730</ArticleId><ArticleId IdType="pubmed">30561613</ArticleId></ArticleIdList></Reference><Reference><Citation>Schellhorn P, Klingel K, Burgstahler C. Return to sports after COVID-19 infection. Eur Heart J. 2020;41(46):4382&#x2013;4384. doi: 10.1093/eurheartj/ehaa448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa448</ArticleId><ArticleId IdType="pmc">PMC7314071</ArticleId><ArticleId IdType="pubmed">32432700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R, Leitl D, Jarosch I, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021;7(2). 10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielmanns M, Pekacka-Egli A-M, Schoendorf S, Windisch W, Hermann M. Effects of a&#xa0;comprehensive pulmonary rehabilitation in severe post-COVID-19 patients. Int J Environ Res Public Health. 2021;18(5):2695. doi: 10.3390/ijerph18052695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052695</ArticleId><ArticleId IdType="pmc">PMC7967422</ArticleId><ArticleId IdType="pubmed">33800094</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Chikhanie Y, Veale D, Schoeffler M, P&#xe9;pin JL, Verges S, H&#xe9;rengt F. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. Respir Physiol Neurobiol. 2021;287:103639. doi: 10.1016/j.resp.2021.103639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103639</ArticleId><ArticleId IdType="pmc">PMC7879818</ArticleId><ArticleId IdType="pubmed">33588090</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a&#xa0;stakeholders&#x2019; conference. Crit Care Med. 2012;40(2):502&#x2013;509. doi: 10.1097/CCM.0b013e318232da75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistarini C, Fiabane E, Houdayer E, Vassallo C, Manera MR, Alemanno F. Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Front Neurol. 2021;12:500. doi: 10.3389/fneur.2021.643646.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.643646</ArticleId><ArticleId IdType="pmc">PMC8165252</ArticleId><ArticleId IdType="pubmed">34079511</ArticleId></ArticleIdList></Reference><Reference><Citation>Piquet V, Luczak C, Seiler F, et al. Do patients with COVID-19 benefit from rehabilitation? Functional outcomes of the first 100 patients in a&#xa0;COVID-19 rehabilitation unit. Arch Phys Med Rehabil. 2021;102(6):1067&#x2013;1074. doi: 10.1016/j.apmr.2021.01.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2021.01.069</ArticleId><ArticleId IdType="pmc">PMC7857995</ArticleId><ArticleId IdType="pubmed">33548208</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese M, Garofano M, Palumbo R, et al. Exercise training and cardiac rehabilitation in COVID-19 patients with cardiovascular complications: state of art. Life. 2021;11(3):259. doi: 10.3390/life11030259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life11030259</ArticleId><ArticleId IdType="pmc">PMC8004041</ArticleId><ArticleId IdType="pubmed">33801080</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhris M, Hillani A, Moroni F, et al. Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol. 2020;36(7):1068&#x2013;1080. doi: 10.1016/j.cjca.2020.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.05.018</ArticleId><ArticleId IdType="pmc">PMC7229739</ArticleId><ArticleId IdType="pubmed">32425328</ArticleId></ArticleIdList></Reference><Reference><Citation>S3-Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas, Deutschland, &#xd6;sterreich, Schweiz (D-A-CH), Langversion &#x2013; 2020 AWMF Registernummer: 133 &#x2013; 001 (Stand: 7. Jan. 2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>